Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
LLY Stock Alert: You Can Now Get Eli Lilly’s Weight Loss Drugs on Amazon
March 13, 2024
Eli Lilly stock is on the move Wednesday morning as investors in LLY shares learn about a new pharmacy partnership with Amazon!
Via
InvestorPlace
Obesity Drugs On Amazon - Eli Lilly Partners With Amazon's Pharmacy Unit To Deliver Drug Prescriptions, Including Popular Zepbound For Weight Loss
March 13, 2024
Amazon Pharmacy integrates LillyDirect, offering home delivery of diabetes, obesity, and migraine medications. Enhance access with prompt doorstep delivery by trusted providers. Eli Lilly's partnership...
Via
Benzinga
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
March 13, 2024
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Via
MarketBeat
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
March 13, 2024
Viking aims to enter a market that may be worth $100 billion in a few years.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
March 12, 2024
Via
Benzinga
Behind the Scenes of Eli Lilly and Co's Latest Options Trends
March 11, 2024
Via
Benzinga
Is Eli Lilly the Best Pharmaceutical Stock for You?
March 09, 2024
Lilly's recently approved weight-loss drug is off to a good start.
Via
The Motley Fool
In-Depth Analysis: Eli Lilly and Co Versus Competitors In Pharmaceuticals Industry
March 08, 2024
Via
Benzinga
Jim Cramer Says Tuesday Rally Was Driven By Nvidia, Eli Lilly And Other 'Stocks Reacting Positively To Good Earnings Per Share News'
March 13, 2024
CNBC's Jim Cramer has highlighted three stocks that are showing signs of recovery after facing consecutive losses.
Via
Benzinga
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
March 12, 2024
AnaptysBio exceeds Q4 2023 earnings expectations, with sales of $9.01 million. Expectations high post-Wedbush upgrade, foreseeing stock surge amid clinical milestones. Analysis compares PD-1 agonist...
Via
Benzinga
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
March 12, 2024
The pharma giant could have yet another knockout obesity drug on the way.
Via
The Motley Fool
Meet the Unknown Small-Cap Company That's Been Paying a Dividend for at Least 66 Years Longer Than Coca-Cola, ExxonMobil, and Eli Lilly
March 12, 2024
A relatively tiny company ($508 million market cap) that most investors have never heard of has been doling out a consecutive dividend for over two centuries -- including 104 years longer than...
Via
The Motley Fool
Gary Black Keeping Tabs On Oprah's Upcoming TV Special About Ozempic — 'Shame, Blame And The Weight Loss Revolution'
March 12, 2024
Future Fund co-founder Gary Black shared details about Oprah Winfrey's upcoming TV special discussing her weight loss journey and the use of GLP-1 weight loss drugs, potentially impacting stocks of...
Via
Benzinga
Forget Tesla: I Think This Stock Should Replace It in the "Magnificent Seven"
March 10, 2024
Tesla doesn't look very magnificent these days. But there's another stock that does.
Via
The Motley Fool
Meet the 5 Stocks That Have Contributed Almost All of the S&P 500's 2024 Gains
March 10, 2024
These companies have contributed the lion's share of the S&P 500's 7% year-to-date gain.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?
March 10, 2024
Encouraging results recently pushed the pharma stock up to new heights.
Via
The Motley Fool
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
March 09, 2024
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
Via
The Motley Fool
The Top 3 Pharma Stocks to Buy in March2024
March 09, 2024
Investors explore the top three biotechnology stocks to buy in 2024 which are leading the anti-obesity market surge.
Via
InvestorPlace
The Best Stocks to Invest $50,000 in Right Now
March 09, 2024
These stalwart companies can help you grow your wealth.
Via
The Motley Fool
S&P 500 Soars To New Highs: 5 Best Stocks Ytd
March 09, 2024
Many semiconductor ETFs also touched new 52-week highs.
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
MarketBeat Week in Review – 3/4 – 3/8
March 09, 2024
The market rally continues as the February Jobs Report reignited the soft landing talk, but momentum could stall if next week's inflation readings come in hot
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Why Eli Lilly Stock Flopped on Friday
March 08, 2024
An important new drug's potential approval has been pushed back, and the timing is unclear.
Via
The Motley Fool
Oprah Winfrey To Spotlight Weight Loss Drugs In New TV Special: Will 'Shame, Blame' Come To Drug Companies — Or Could They Get Another Lift?
March 08, 2024
Weight loss drugs could get an increased spotlight with a television special from legendary TV host Oprah Winfrey.
Via
Benzinga
Novo Nordisk Wins FDA Approval For Obesity Drug, Wegovy, To Cut Cardiovascular Risk
March 08, 2024
Novo Nordisk stock slumped despite winning FDA approval for its Wegovy in reducing cardiovascular risks.
Via
Investor's Business Daily
Exposures
Product Safety
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
BenevolentAI CEO Dr Joerg Moeller discusses AI's impact on drug discovery
March 08, 2024
--News Direct--
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
BenevolentAI CEO Dr Joerg Moeller discusses AI's impact on drug discovery
March 08, 2024
BenevolentAI CEO Dr Joerg Moeller tells Proactive's Stephen Gunnion how the company is positioning itself as a pioneer in AI-augmented drug discovery, aiming to enhance the success rates of drug...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Stock Market Rally Hits Fresh Highs As Nvidia, Novo Nordisk, Bitcoin Soar: Weekly Review
March 08, 2024
The Nasdaq and S&P 500 hit new all-time highs.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Are These 5 Undervalued Stocks Ready to Break Out?
March 08, 2024
Undervalued stocks Albemarle, Ionis, Insulet, Hess and Wynn beat earnings views, offering potential for investors to buy quality companies at discounted prices.
Via
MarketBeat
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
March 08, 2024
The FDA's upcoming advisory committee meeting on Eli Lilly's Phase 3 donanemab trial for early symptomatic Alzheimer's. Understand safety and efficacy considerations, with a delay in expected FDA...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.